Zdrowie i gospodarka · 01/02/2006

FDA Proposes Rule to Allow Registered Blood Establishments to Distribute Blood Derivatives

The FDA is proposing a rule change to allow certain registered blood establishments that qualify as healthcare entities to distribute blood derivatives, which are derivatives of blood, if finalized. This change would amend certain provisions of the Prescription Drug Marketing Act of 1987 and the Prescription Drug Amendments of 1992.